Mehra Anand

CIK 000159010215 companiesMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001590102

Recent Transactions

50 trades

Disposition to Issuer
Merus N.V.$MRUS
Share Option (right to buy)
2025-12-12−6,120→ 0 total
Disposition to Issuer
Merus N.V.$MRUS
Share Option (right to buy)
2025-12-12−13,193→ 0 total
Disposition to Issuer
Merus N.V.$MRUS
Share Option (right to buy)
2025-12-12−5,650→ 0 total
Disposition to Issuer
Merus N.V.$MRUS
Share Option (right to buy)
2025-12-12−17,000→ 0 total
Disposition to Issuer
Merus N.V.$MRUS
Share Option (right to buy)
2025-12-12−4,983→ 0 total
Disposition to Issuer
Merus N.V.$MRUS
Share Option (right to buy)
2025-12-12−14,414→ 0 total
Disposition to Issuer
Merus N.V.$MRUS
Share Option (right to buy)
2025-12-12−8,844→ 0 total
Disposition to Issuer
Merus N.V.$MRUS
Share Option (right to buy)
2025-12-12−8,500→ 0 total
Disposition to Issuer
Merus N.V.$MRUS
Share Option (right to buy)
2025-12-12−8,631→ 0 total
Disposition to Issuer
Merus N.V.$MRUS
Share Option (right to buy)
2025-12-12−16,604→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-06-06−4,793→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-06-06+4,793→ 714,823 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2025-06-05+42,350→ 42,350 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-06-05+11,580→ 11,580 total
Award
Merus N.V.$MRUS
Share Option (right to buy)
2025-05-22+13,193→ 13,193 total
Purchase
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-11-19$2.25/sh+666,666→ 710,030 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2024-06-06+15,750→ 15,750 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-06-06+4,793→ 4,793 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-06-01−4,660→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-06-01+4,660→ 43,364 total
Award
Merus N.V.$MRUS
Share Option (right to buy)
2024-05-07+8,844→ 8,844 total
Award
Merus N.V.$MRUS
Share option (right to buy)
2023-06-08+14,414→ 14,414 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-06-02−4,507→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-06-02+4,507→ 38,704 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-06-01+4,660→ 4,660 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2023-06-01+15,750→ 15,750 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-06-03+3,356→ 34,197 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-06-03−3,356→ 0 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2022-06-02+15,750→ 15,750 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-06-02+4,507→ 4,507 total
Award
Merus N.V.$MRUS
Share option (right to buy)
2022-05-31+16,604→ 16,604 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2021-06-03+12,250→ 12,250 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2021-06-03+3,356→ 3,356 total
Award
Merus N.V.$MRUS
Share option (right to buy)
2021-05-28+6,120→ 6,120 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Option Grant (right to buy)
2021-02-02−6,632→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Option Grant (right to buy)
2021-02-02−8,000→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-02-02$18.32/sh+6,632→ 30,841 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-02-02$18.35/sh+8,000→ 24,209 total
Award
Merus N.V.$MRUS
Share Option (right to buy)
2020-06-30+8,631→ 8,631 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2020-06-06−7,333→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2020-06-06+7,333→ 16,209 total
Award
Aclaris Therapeutics, Inc.$ACRS
Option Grant (right to buy)
2020-06-04+16,500→ 16,500 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2020-03-02+8,876→ 8,876 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2020-03-02−8,876→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2020-03-02+8,876→ 8,876 total
Disposition to Issuer
Spark Therapeutics, Inc.
Stock Option (Right to Buy)
2019-12-17−6,000→ 0 total
Disposition from Tender
Spark Therapeutics, Inc.
Common Stock
2019-12-17$114.50/sh−40,203→ 0 total
Disposition from Tender
Spark Therapeutics, Inc.
Common Stock
2019-12-17$114.50/sh−481,270→ 0 total
Disposition to Issuer
Spark Therapeutics, Inc.
Stock Option (Right to Buy)
2019-12-17−4,000→ 0 total
Disposition to Issuer
Spark Therapeutics, Inc.
Stock Option (Right to Buy)
2019-12-17−4,000→ 0 total

Mehra Anand

Recent Transactions

Companies

Recent Filings

Address